SCHEMBL25367646

SCHEMBL25367646

COc1cc(Br)cc(COC(N)=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP15 Q460N3 2/20 0.41
CYP3A4 P08684 3/20 0.40
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
IDO1 P14902 1/20 0.38
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 2/20 0.37
POLB P06746 1/20 0.36
HPGD P15428 2/20 0.36
MAOB P27338 1/20 0.36
PARP14 Q460N5 1/20 0.35
PARP10 Q53GL7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112110 0.88 KMT2A (0.44) CYP3A4GRIN2DGRIN3BGRIN1GRIN2A
Carbamic Acid SCHEMBL27856575 0.85 L3MBTL1 (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL28637839 0.80 CA1 (0.35) GRIN2BIDO1ALDH1A1POLBHPGD
SCHEMBL27809634 0.77 IDO1 (0.41) PARP15IDO1MAOBPARP14PARP10
SCHEMBL31366713 0.76 TACR1 (0.48) KMT2APOLBMAOBLMNA
SCHEMBL6139463 0.75 IDO1 (0.62) CYP1A2IDO1ALDH1A1MAOBMMP2
SCHEMBL10350883 0.75 PTGS1 (0.51) ALDH1A1POLBLMNA
SCHEMBL155140 0.74 ALDH1A1 (0.57) CYP3A4CYP2C19IDO1ALDH1A1POLB
SCHEMBL30035215 0.74 SMN1; SMN2 (0.47) CYP3A4CYP2C19CYP1A2CYP2D6KMT2A
SCHEMBL18554389 0.73 HSP90AB1 (0.53) CYP3A4CYP2C19KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023158221-A1 PHARMACEUTICAL COMPOSITION FOR TREATING CANCER, COMPRISING ANTICANCER AGENT AND NOVEL COMPOUND HAVING INHIBITORY ACTIVITY WITH RESPECT TO PROSTAGLANDIN E2 RECEPTORS 주식회사 카나프테라퓨틱스 2023-08-24 WO disclosed
CN-116529238-A Novel prostaglandin E 2 Compounds with receptor inhibiting activity and uses thereof 治纳辅医药科技有限公司 2023-08-01 CN disclosed